Health and Wellness

Hospitals Lose $32 Billion If Congress Doesn’t Extend ACA Tax Credits

Senator John Barrasso, a Republican from Wyoming; Senate Majority Leader John Thune, a Republican from South Dakota; and Senator Steve Daines, a Republican from Montana, addressed a news conference at

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.

Lasted Health and Wellness

Women’s health has federal offices. Should men have one, too?

The early 1990s marked a pivotal moment in female health advocacy, with the establishment of various offices and initiatives to

Leucovorin, Jeffrey Epstein, sex differences: Morning Rounds

Health and medicine are crucial aspects of our daily lives, and staying informed about the latest developments in the field

FDA approves leucovorin for rare disorder, not for autism

The Food and Drug Administration recently approved a drug to treat a rare brain disorder that resembles autism. The medication,

Dana-Farber and Brigham breakup latest: tensions and resolution

The recent breakup between Dana-Farber Cancer Institute and Mass General Brigham has taken a surprisingly amicable turn, with the institutions

HHS autism, Himsification, kidney transplant: Morning Rounds

The cancellation of a federal advisory committee on autism, the Interagency Autism Coordinating Committee, has caused quite a stir in

Dropping race from test helps Black Americans get kidney transplants

In the past, nephrologists made a groundbreaking effort to eliminate race from a crucial clinical algorithm in an attempt to

FDA Vinay Prasad, Ozempic, autism diagnosis: Morning Rounds

Fresh turmoil at the FDA with Prasad’s exit Vinay Prasad, who served as the head of the Center for Biological

FDA advisory committee meetings fade as controversial decisions grow

The Trump administration recently organized a private press conference to address concerns about an experimental treatment for Huntington's disease developed